CROS NT extends Medidata partnership

By Melissa Fassbender contact

- Last updated on GMT

ICH GCP E6(R2) guidelines outline a risk-based approach to clinical trial monitoring. (Image: iStock/liuzishan)
ICH GCP E6(R2) guidelines outline a risk-based approach to clinical trial monitoring. (Image: iStock/liuzishan)

Related tags: Trial supply management, Contract research organization

The extended partnership provides CROS NT customers access to Medidata’s electronic data capture (EDC) solution as well as its randomization and trial supply management system (RTSM).

Andrew MacGarvey, CEO of CROS NT, told Outsourcing-Pharma.com the company needs a number of systems in its portfolio to serve its customer’s various needs – “and the Medidata products form an important part of our offering​,” he said.

As part of the extended relationship, CROS NT gains access to RaveX, the latest generation of Medidata's EDC system Medidata Rave, and Medidata Balance, a randomization and trial supply management (RTSM) system.

RaveX is an ideal technology to support sponsors implementing a risk-based approach to clinical trials by improving the quality of data coming from sites,”​ MacGarvey said, noting the ICH GCP E6(R2) guidelines​ that come into effect this June.

By adding RaveX to our portfolio of technologies, we are further equipped to help sponsors implement their risk-based clinical and data strategy​,” he added.

Medidata has also trained and accredited the contract research organization’s (CRO) data management team.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Standardizing data with NCI controlled terminology

Standardizing data with NCI controlled terminology

Formedix | 18-Jul-2022 | Technical / White Paper

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND...

Planning Your First-In-Human Trial

Planning Your First-In-Human Trial

Altasciences | 15-Jul-2022 | Technical / White Paper

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug. A successfully conducted FIH trial provides...

Related suppliers

Follow us

Products

View more

Webinars